Corrigendum to “Safety and feasibility of CDK4/6 inhibitors treatment combined with radiotherapy in patients with HR-positive/HER2-negative breast cancer. A systematic review and meta-analysis” [Radiother. Oncol. 187 (2023) 109839]

After publication of the abovementioned article, the authors regret that the Funding section was incomplete. The correct Funding information has been printed below.

Source: Radiotherapy and Oncology - March 6, 2024 Category: Radiology Authors: Marcin Kubeczko, Micha ł Jarząb, Dorota Gabryś, Aleksandra Krzywon, Alexander J. Cortez, Amy J. Xu Tags: Systematic Review Source Type: research